You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: 8,547,248


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,547,248
Title:Implantable zero-wire communications system
Abstract: The present invention provides implantable systems that communicate wirelessly with each other using a unique format that enables devices configurations and applications heretofore not possible. Embodiments of the present invention provide communication apparatuses and methods for exchanging information with implantable medical devices. In some embodiments, two implantable devices communicate with each other using quasi-electrostatic signal transmission in a long wavelength/low frequency electromagnetic band, with the patient's body acting as a conductive medium.
Inventor(s): Zdeblick; Mark J. (Portola Valley, CA), Robertson; Timothy (Belmont, CA)
Assignee: Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:12/063,095
Patent Claim Types:
see list of patent claims
Use; Delivery; Device;
Patent landscape, scope, and claims:

United States Patent 8,547,248: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 8,547,248, titled "Implantable zero-wire communications system," is a significant innovation in the field of medical technology. This patent, granted to various inventors, outlines a system for wireless communication between implantable medical devices. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Title and Abstract

The patent titled "Implantable zero-wire communications system" describes a system designed for wireless communication between implantable medical devices. This system enables devices to communicate without the need for physical wires, enhancing the functionality and safety of implantable medical devices[4].

Scope of the Patent

Technical Description

The patent details an implantable system that communicates wirelessly using a unique format. This includes devices configured to deliver electrical stimulation, sensors to monitor physiological parameters, and power sources adapted for wireless power delivery. The system is designed to be efficient and safe, with various embodiments illustrating different configurations and applications[4].

Key Components

  • Remote Devices: These are implanted at various locations in the body and can include effector units to deliver electrical stimulation to tissues.
  • Power Source: Adapted for wireless power delivery, ensuring continuous operation without the need for physical connections.
  • Communication Link: Utilizes electromagnetic coupling or other wireless communication methods to exchange information between devices[4].

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the core inventions. These claims cover the system as a whole, including the remote devices, the power source, and the communication method. For example:

  • Claim 1 describes the implantable system comprising multiple remote devices and a transmitter unit for wireless communication.
  • Claim 10 details the method of wirelessly powering the remote devices using reverse electrolysis or other means[4].

Dependent Claims

Dependent claims further specify the details of the invention, such as the configuration of the remote devices, the type of sensors used, and the specific communication protocols. These claims help to narrow down the scope and ensure that the patent covers all aspects of the invention[4].

Patent Landscape

International Patent Offices

The patent landscape for similar inventions can be explored through various international patent offices. For instance, the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) provide searchable databases that can help identify similar patents and prior art[1].

Related Patents and Applications

Using tools like the Common Citation Document (CCD) and Global Dossier, one can identify related patent applications and prior art cited by multiple offices. This helps in understanding the broader context and potential overlaps or innovations in the field[1].

Classification and Citation Data

The patent is classified under various categories such as A61N1/32, A61N1/36, and H02J50/00, indicating its relevance to medical devices, electrical stimulation, and wireless power distribution. The citation data from CCD can provide insights into how this patent fits into the global patent landscape and its impact on subsequent inventions[1][4].

Economic and Research Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset can provide detailed information on claims from U.S. patents, including those related to medical devices. This dataset helps in analyzing the scope and trends of patent claims, offering valuable insights for researchers and economists[3].

Industry Impact

The implantable zero-wire communications system has significant implications for the medical device industry. It enhances patient safety, reduces the risk of infection associated with wired devices, and improves the overall efficiency of implantable medical devices. This innovation can drive further research and development in wireless medical technologies.

Legal Status and Expiration

The patent is currently active but has an expiration date based on the filing and grant dates. It is crucial to monitor the legal status, as it affects the rights and obligations of the patent holders and potential users of the technology[4].

Conclusion

United States Patent 8,547,248 represents a groundbreaking innovation in wireless communication for implantable medical devices. Understanding the scope, claims, and the broader patent landscape is essential for researchers, inventors, and industry professionals. This analysis highlights the technical, economic, and legal aspects of the patent, providing a comprehensive view of its significance and impact.

Key Takeaways

  • The patent describes an implantable system for wireless communication between medical devices.
  • Key components include remote devices, wireless power sources, and communication links.
  • The patent has significant implications for patient safety and the medical device industry.
  • Understanding the patent landscape through international databases and citation data is crucial.
  • The patent's legal status and expiration date are important for rights and obligations.

Frequently Asked Questions (FAQs)

What is the main innovation of United States Patent 8,547,248?

The main innovation is an implantable system that enables wireless communication between medical devices, eliminating the need for physical wires.

How does the system power the remote devices?

The system uses wireless power delivery methods, such as reverse electrolysis, to power the remote devices.

What are the potential benefits of this invention?

The invention enhances patient safety by reducing the risk of infection associated with wired devices and improves the overall efficiency of implantable medical devices.

How can one search for related patents and prior art?

One can use tools like the Common Citation Document (CCD), Global Dossier, and international patent office databases such as the EPO, JPO, and WIPO.

What is the significance of the Patent Claims Research Dataset in this context?

The dataset provides detailed information on claims from U.S. patents, helping in analyzing the scope and trends of patent claims, which is valuable for researchers and economists.

Cited Sources:

  1. USPTO - Search for patents
  2. DrugPatentWatch - Patent 8,547,248
  3. USPTO - Patent Claims Research Dataset
  4. Google Patents - US8547248B2
  5. PubChem - Implantable Zero-Wire Communications System

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,547,248

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-001 Nov 13, 2017 RX Yes No 8,547,248 ⤷  Subscribe Y METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER ⤷  Subscribe
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-002 Nov 13, 2017 RX Yes Yes 8,547,248 ⤷  Subscribe Y METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER ⤷  Subscribe
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-003 Nov 13, 2017 RX Yes No 8,547,248 ⤷  Subscribe Y METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER ⤷  Subscribe
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-004 Nov 13, 2017 RX Yes No 8,547,248 ⤷  Subscribe Y METHOD OF USING A TABLET EMBEDDED WITH A SENSOR THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,547,248

PCT Information
PCT FiledSeptember 01, 2006PCT Application Number:PCT/US2006/034258
PCT Publication Date:March 08, 2007PCT Publication Number: WO2007/028035

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.